HomeDoximity Announces Fiscal 2022 Second Quarter Financial Results

Doximity Announces Fiscal 2022 Second Quarter Financial Results

Cision

Total revenues of $79.4 million, up 76% year-over-year

Net income margin of 45% and adjusted EBITDA margin of 41%

SAN FRANCISCO, Nov. 9, 2021 /PRNewswire/ — Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results for the fiscal 2022 second quarter ended September 30, 2021.

“We’re pleased to report another strong financial quarter as the shift to digital among our clients continues,” said Jeff Tangney, co-founder & CEO at Doximity. “We’re particularly proud that our existing clients generated a record 173% net revenue retention rate (for the trailing 12 months), and that our telehealth platform grew to a record of over 330,000 active providers.”

Fiscal 2022 Second Quarter Financial Highlights:

All comparisons, unless otherwise noted, are to the three months ended September 30, 2020.

  • Revenue: Revenue of $79.4 million versus $45.1 million, an increase of 76% year-over-year.
  • Net income and non-GAAP net income: Net income of $36.1 million versus $10.0 million, representing a 45% margin. Non-GAAP net income of $41.6 million, versus $11.2 million, representing a 52% margin.
  • Adjusted EBITDA: Adjusted EBITDA of $32.8 million versus $12.6 million, an increase of 160% year-over-year, representing adjusted EBITDA margins of 41%, versus 28%.
  • Net income per share and non-GAAP net income per share: Diluted net income per share was $0.17, versus $0.02, while non-GAAP diluted net income per share was $0.19, versus $0.02.
  • Operating cash flow and free cash flow: Operating cash flow of $19.2 million, versus $12.7 million, and free cash flow of $18.1 million, versus $11.3 million.

Financial Outlook

Doximity is providing guidance for its fiscal third quarter ending December 31, 2021 as follows:

Doximity is updating guidance for its fiscal year ending March 31, 2022 as follows:

Lock-up Expiry on November 12, 2021

In connection with the Company’s initial public offering of Class A common stock, its executive officers, directors, and substantially all of its stockholders were parties to lock-up agreements that restrict their ability to sell or transfer their Doximity shares. Pursuant to the terms of the lock-up agreements, the lock-up will expire at the opening of trading on November 12, 2021. Certain of the shares of the Company’s common stock that become eligible for sale in the public market upon the lock-up expiration remain subject to volume and other restrictions of Rule 144 of the Securities Act of 1933, as amended, and restrictions on insider trading in accordance with Company policy.

Conference Call Information

Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.

About Doximity

Founded in 2010, Doximity is the leading digital platform for medical professionals. The company’s network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers, and conduct virtual patient visits. Doximity’s mission is to help doctors be more productive so they can provide better care for their patients. For more information, please visit www.doximity.com.

Forward-Looking Statements

Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the impact of the COVID-19 pandemic (including the impact to our industry or on our customers’ industries, impact on general economic conditions, and government responses, restrictions, and actions related to the pandemic); (ii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iii) our ability to attract new customers or retain existing customers; (iv) the impact of our prioritization of our members’ interests; (v) breaches in our security measures or unauthorized access to members’ data; (vi) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in the prospectus for our recent offering of shares of Class A common stock shares that was filed with the SEC on June 25, 2021, and in our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, as such risk factors may be updated from time to time in our periodic filings with the SEC. Additional information will be provided in our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Investor Relations Contact:
Perry Gold
ir@doximity.com

Media Contact:
pr@doximity.com

DOXIMITY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
September 30, 2021 March 31, 2021
Assets
Current assets:
Cash and cash equivalents $ 79,521 $ 66,393
Marketable securities 663,140 76,141
Accounts receivable, net 55,681 50,319
Prepaid expenses and other current assets 28,159 10,692
Deferred contract costs, current 3,107 5,856
Total current assets 829,608 209,401
Property and equipment, net 8,004 7,598
Deferred income tax assets 2,112 2,112
Operating lease right-of-use assets 770 1,339
Intangible assets, net 9,067 9,596
Goodwill 18,915 18,915
Other assets 779 2,758
Total assets $ 869,255 $ 251,719
Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity
Current liabilities:
Accounts payable $ 781 $ 1,515
Accrued expenses 15,664 16,285
Deferred revenue, current 78,681 83,272
Operating lease liabilities, current 498 970
Total current liabilities 95,624 102,042
Deferred revenue, non-current 49 220
Operating lease liabilities, non-current 118 284
Other liabilities, non-current 904 972
Total liabilities 96,695 103,518
Redeemable Convertible Preferred Stock
Redeemable convertible preferred stock 81,458
Stockholders’ Equity
Preferred stock
Common stock 187 83
Additional paid-in capital 674,414 30,357
Accumulated other comprehensive loss (775) (21)
Retained earnings 98,734 36,324
Total stockholders’ equity 772,560 66,743
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity $ 869,255 $ 251,719
DOXIMITY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three Months Ended
September 30,
Six Months Ended
September 30,
2021 2020 2021 2020
Revenue $ 79,350 $ 45,113 $ 152,019 $ 81,501
Cost of revenue(1) 8,951 7,456 16,937 15,331
Gross profit 70,399 37,657 135,082 66,170
Operating expenses(1):
Research and development 15,460 9,866 28,701 19,909
Sales and marketing 21,161 14,145 40,532 27,430
General and administrative 8,827 3,209 16,023 6,311
Total operating expenses 45,448 27,220 85,256 53,650
Income from operations 24,951 10,437 49,826 12,520
Interest income 440 73 516 210
Other expense, net (20) (93) (51) (383)
Income before income taxes 25,371 10,417 50,291 12,347
Provision for (benefit from) income taxes (10,717) 380 (12,119) 851
Net income $ 36,088 $ 10,037 $ 62,410 $ 11,496
Undistributed earnings attributable to participating securities (8,354) (18,326) (9,122)
Net income attributable to Class A and Class B common stockholders, basic and diluted $ 36,088 $ 1,683 $ 44,084 $ 2,374
Net income per share attributable to Class A and Class B common stockholders:
Basic $ 0.19 $ 0.02 $ 0.32 $ 0.03
Diluted $ 0.17 $ 0.02 $ 0.27 $ 0.03
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic 186,171 70,591 137,154 69,988
Diluted 216,672 91,830 166,066 88,498
(1) Costs and expenses include share-based compensation expenses as follows:
Three Months Ended
September 30,
Six Months Ended
September 30,
2021 2020 2021 2020
Cost of revenue $ 793 $ 99 $ 1,061 $ 189
Research and development 1,859 281 2,829 545
Sales and marketing 1,866 376 2,894 671
General and administrative 2,154 423 5,015 757
Total stock-based compensation expense $ 6,672 $ 1,179 $ 11,799 $ 2,162
DOXIMITY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Three Months Ended
September 30,
Six Months Ended
September 30,
2021 2020 2021 2020
Cash flows from operating activities
Net income $ 36,088 $ 10,037 $ 62,410 $ 11,496
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization 1,158 928 2,311 1,696
Deferred income taxes 260 623
Stock-based compensation, net of amounts capitalized 6,672 1,179 11,799 2,162
Other (72) 44 (70) 105
Non-cash lease expense 286 643 569 1,294
Bad debt expense (recovery) 288 (84) 195 4
Amortization of premium on marketable securities, net 1,264 9 1,561 14
Amortization of prepaid partner fees 231 799
Amortization of deferred contract costs 2,452 1,593 5,656 3,140
Changes in operating assets and liabilities, net of effect of acquisition:
Accounts receivable (9,978) (4,028) (5,556) (14,890)
Prepaid expenses and other assets (14,867) (2,707) (18,191) 763
Deferred contract costs (1,483) (1,275) (2,975) (2,755)
Accounts payable (420) 89 (292) (275)
Accrued expenses 1,958 181 (419) (643)
Deferred revenue (4,198) 6,496 (4,763) 18,543
Operating lease liabilities (167) (650) (638) (1,310)
Other liabilities (60) (14) (69) 1,494
Net cash provided by operating activities 19,152 12,701 52,327 21,461
Cash flows from investing activities
Purchases of property and equipment (200) (67) (241) (92)
Capitalized internal-use software (900) (1,379) (1,671) (2,530)
Purchases of marketable securities (1,088,768) (1,156,143)
Maturities of marketable securities 24,787 16,000 35,551 34,000
Sales of marketable securities 531,076 531,076
Cash paid for acquisition, net of cash acquired (31,634)
Other (25) (25)
Net cash provided by (used in) investing activities (534,005) 14,529 (591,428) (281)
Cash flows from financing activities
Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions 553,905
Payments of deferred offering costs (2,214) (3,982)
Proceeds from issuance of common stock upon exercise of stock options 2,323 1,124 5,060 1,347
Taxes paid related to net share settlement of equity awards (56) (56)
Repurchase and retirement of common stock (2,698)
Net cash provided by financing activities 53 1,124 552,229 1,347
Net increase (decrease) in cash and cash equivalents (514,800) 28,354 13,128 22,527
Cash and cash equivalents, beginning of period 594,321 42,603 66,393 48,430
Cash and cash equivalents, end of period $ 79,521 $ 70,957 $ 79,521 $ 70,957

Non-GAAP Financial Measures

To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:

  • Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP net income, non-GAAP net income margin, and non-GAAP basic and diluted net income per common share: We exclude the effect of stock-based compensation expense-related charges, amortization of acquired intangible assets, and expenses associated with acquisitions from non-GAAP gross profit, non-GAAP gross margin and non-GAAP operating income. Non-GAAP net income and non-GAAP net income margin are further adjusted for estimated income tax on such adjustments. We calculate income taxes on the adjustments by applying an estimated annual effective tax rate to the adjustments. Non-GAAP basic and diluted net income per common share is non-GAAP net income attributable to common stockholders divided by the weighted average number of shares. For both basic and diluted non-GAAP net income per share, the weighted average shares we use in computing non-GAAP net income per share is equal to our GAAP weighted average shares. Non-GAAP gross margin represents non-GAAP gross profit as a percentage of revenue and non-GAAP net income margin represents non-GAAP net income as a percentage of revenue.
  • Adjusted EBITDA and adjusted EBITDA margin: We define adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization, and as further adjusted for acquisition and other related expenses, stock-based compensation expense, and other (income) expense, net. Adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.
  • Free cash flow: We calculate free cash flow as cash flow from operating activities less purchases of property and equipment and capitalized internal-use software development cost.

We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results.

Key Business Metrics

  • Net revenue retention rate: We calculate net revenue retention rate by taking the trailing 12-month (“TTM”) subscription-based revenue from our customers that had revenue in the prior TTM period and dividing that by the total subscription-based revenue for the prior TTM period. Our net revenue retention rate compares our subscription revenue from the same set of customers across comparable periods, and reflects customer renewals, expansion, contraction, and churn.
  • Customers with trailing 12-month subscription revenue greater than $100,000: We calculate the number of customers with trailing 12-month (“TTM”) product revenue greater than $100,000 by counting the number of customers that contributed more than $100,000 in subscription revenue in the TTM period. The number of customers with TTM subscription-based revenue of at least $100,000 is a key indicator of the scale of our business.

Reconciliation of GAAP to Non-GAAP Financial Measures

The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:

Three Months Ended
September 30,

Six Months Ended
September 30,

2021

2020

2021

2020

(unaudited)

(unaudited)

(in thousands)

(in thousands)

Net income

$

36,088

$

10,037

$

62,410